We showed that the MYO10 mRNA expression ratio can be used as an independent prognostic factor for survival of patients with resected lung squamous cell carcinoma and propose that MYO10 may represent a new molecular target for therapeutic intervention. The gene discussed is MYO10; the disease is squamous cell lung carcinoma.